BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 3811723)

  • 1. [Features of the clinical picture, course and treatment of myasthenia in late middle-aged and aged persons].
    Gladyshev SS; Gekht BM; Kolomenskaia EA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(11):1633-8. PubMed ID: 3811723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Variants of the pathogenetic therapy of myasthenia gravis].
    Lobzin VS; Poliakova LA; Fedotova TA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(11):1609-14. PubMed ID: 3434054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of therapeutic plasmapheresis in patients with generalized myasthenia during exacerbations in the late period following thymectomy].
    Marchuk AI; Golovteev VV; Sapin SM; Shagal DI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):330-3. PubMed ID: 3705836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major review: the clinical spectrum of pediatric myasthenia gravis: blepharoptosis, ophthalmoplegia and strabismus. A report of 14 cases.
    McCreery KM; Hussein MA; Lee AG; Paysse EA; Chandran R; Coats DK
    Binocul Vis Strabismus Q; 2002; 17(3):181-6. PubMed ID: 12171588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical spectrum of myasthenia gravis and problems of management.
    Dhamija RM; Venkataraman S; Roy AK; Sanchetee PC; Bhargava AK
    J Assoc Physicians India; 1991 Feb; 39(2):181. PubMed ID: 1885481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience with programmed steroid treatment with thymectomy in nonthymomatous myasthenia gravis.
    Endo S; Yamaguchi T; Saito N; Otani S; Hasegawa T; Sato Y; Sohara Y
    Ann Thorac Surg; 2004 May; 77(5):1745-50. PubMed ID: 15111178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Corticosteroid therapy combined with thymectomy in myasthenia gravis].
    Ito N; Hirayama K; Baba M; Yamaguchi Y; Kuroda N
    Rinsho Shinkeigaku; 1983 Apr; 23(4):338-46. PubMed ID: 6883880
    [No Abstract]   [Full Text] [Related]  

  • 8. [Diagnosis, surgical treatment and prognosis in patients with generalized myasthenia].
    Kuzin MI; Shkrob OS; Gekht BM; Vetshev PS; Zaĭratíants OV; Kuznetsov NS; Chilingaridi KE; Voronov LI; Ippolitov IKh; Kurochkin AV
    Khirurgiia (Mosk); 1993 Apr; (4):11-20. PubMed ID: 8084163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indication of thymectomy and immunotherapies on myasthenia gravis].
    Murai H
    Rinsho Shinkeigaku; 2007 Nov; 47(11):875-6. PubMed ID: 18210823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transsternal thymectomy for myasthenia gravis: surgical outcome.
    Kattach H; Anastasiadis K; Cleuziou J; Buckley C; Shine B; Pillai R; Ratnatunga C
    Ann Thorac Surg; 2006 Jan; 81(1):305-8. PubMed ID: 16368387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymectomy for myasthenia gravis in the young adult. Long-term results.
    Clark RE; Marbarger JP; West PN; Spratt JA; Florence JM; Roper CL; Ferguson TB; Weldon CS
    J Thorac Cardiovasc Surg; 1980 Nov; 80(5):696-701. PubMed ID: 7431966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the results of different therapeutic measures in 198 myasthenia gravis patients.
    Apostolski S; Lavrnić D; Djukić P; Trikić R; Gospavić J; Dotlić R; Pavlović S
    Monogr Allergy; 1988; 25():86-95. PubMed ID: 3173364
    [No Abstract]   [Full Text] [Related]  

  • 13. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
    Kunze K
    Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
    [No Abstract]   [Full Text] [Related]  

  • 14. Myasthenia gravis: effect of immunoactive therapies.
    Fornádi L; Horváth R; Bárdosi Z; Szobor A
    Acta Med Hung; 1994; 50(1-2):83-92. PubMed ID: 7638045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Significance of thymectomy for the treatment of myasthenia gravis pseudoparalytica].
    Becker H; Ungeheuer E
    Med Klin; 1973 Jun; 68(22):731-5. PubMed ID: 4715781
    [No Abstract]   [Full Text] [Related]  

  • 16. [Myasthenia gravis. Longitudinal course and therapeutic aspects].
    Klingler D; Necek S; Brücke P
    Wien Med Wochenschr; 1978 Jun; 128(12):348-52. PubMed ID: 664725
    [No Abstract]   [Full Text] [Related]  

  • 17. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
    Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
    Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Splenectomy in the treatment of severe generalized myasthenia gravis (first experience)].
    Kuzin MI; Shkrob OS; Gekht BM; Vetshev PS; Shagal DI; Zaĭrat'iants OV; Khodzhaev ZSh; Ippolitov IKh
    Khirurgiia (Mosk); 1990 Aug; (8):95-9. PubMed ID: 2259184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable results of thymectomy combined with prednisolone alternate-day administration in myasthenia gravis.
    Yamaguchi Y; Saito Y; Baba M; Obata S
    Jpn J Surg; 1987 Jan; 17(1):14-20. PubMed ID: 3573441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Features of the clinical picture and results of the treatment of myasthenia in Uzbekistan].
    Samibaev MKh; Gabrielian MI; Allaz-ogly N
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(11):1658-61. PubMed ID: 2934919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.